Ampersand Bio Share Class Level Preferred Share Class Type (AMPEPBX)

“ Bottom Line Eliminating the $600K interest expense is economically equivalent to adding $600K revenue (and actually slightly better).”Straight up lie. You cannot just eliminate expense because this company cannot pay it. You are a LIAR. FRAUD. CHARLATAN.

PMI has a 15 to 1 up to 50 to 1 Reverse Split scheduled for the Annual Meeting July 17th -

Not a fan of RS - I would rather have a company build value instead of stealing shares for an artificial increase in share price.

Wow wow wow…so I have seen that post and seen a few clinical research peptide products on MSKsignal website but only few days ago when I did some research on peptides in black market. BPC-157 stuck out to me. It’s one of the 19 peptides in the U.S FDA is about to clear for compounding.
Been d

So, you going to file suit here or what ?  You keep showcasing all this for what reason ?

USIO Purchase of PostCredit, Pros & Cons:

Positive
All-stock acquisition of PostCredit assets announced Nov 25, 2025
Adds AI-driven expense-management with receipt ingestion and automatic tagging
Planned integration with payments, ACH, real-time payments, and card

very little even coming out of Devmar Developement overall these days , the CFO shows there and another company now. HMMM

TMM, Inc.’s (TMMI) legacy TRUDEF™ and VDK3 track directly shapes how the company can pivot toward Artificial Intelligence (AI) technology in 2026 and beyond....

While the company historically failed to achieve mainstream distribution as a consumer video codec,
its fundament

Hey William S. Rukeyser, er, I mean Pennywise100. First, I was taking the mick about the ‘trade by appointment’ but apparently you didn’t catch that.

You might very well be right. You may be wrong. Time will tell.

The thing is most of us have skin in the game here, wh

KUDOS for this post on 11/14/2025---were you also privately threatened by KING BOOB for besmerching their sterling names?

Oh no. The dreaded Roxanna Lou Green aka Roxanna Weber and Dorliss Bright. They issued just under 500m to Dorliss Bright for "consultation services" back in Septe

BIEL: The 4-PR Path to Copper (Momentum Engine)
The June 17 PR didn’t move the PPS because it added no new catalysts — no numbers, no channels, no timelines, no launch, no traction metrics .
To reach COPPER, BIEL needs a sequenced PR engine that builds pressure every 7–14 days until th

Really, well jolly good. Send an email should you find something better and include your thorough DD this next time.

What will you say when nothing concerning approval happens in the next few weeks?

An institutional and market structure analysis confirms that the massive increase in GBT Technologies Inc. (OTC: GTCH) outstanding shares (OS) is directly connected to the structural mechanics of financing the Two Hands Corporation (OTC: TWOH) acquisition.The underlying mechanics of this relationshi

You are confusing 'investing' with 'winning the lottery.' I have zero interest in gambling on narratives or riding a speculative cycle to chase a quick dollar. I analyze businesses for their long-term solvency and structural integrity. If you want to play the slots, that’s your business—but don't ca

I feel the same way…PR approval, next week…I guess Wednesday a.m. At the start of BNOS…If next week, the excitement at BNOS will be unprecedented!

You should really stop investing in pharma/biotech if this is your understanding of the approval process.

You keep talking about 'investing' and 'being right' based on price action, completely missing the mechanics of how this game is actually played.

When the 'big fish' set a narrative and drive prices, they aren't just 'investing'—they are operating with visibility and tools that retail

Well it’s a matter of perspective. It IS a penny stock after all. Everyone should know the risks of that. I’m betting this will be be a Nasdaq darling one day. However , I’m prepared to lose it all. Always have been. It really started out as a high stakes gamble for me. Today , more and more I feel

The compassionate use program has NOT ended; it is still valid and continuing with approximately 70 people continuing today!!!

GOD bless,

Got news for you, pal. I am not -repeat
NOT- selling any of my BIEL shrews. Either are the true BIEL longs.
You’ll know why soon.
Sufficiently said!




BUY $BIEL$

Here's how I see AdiaMed:

Pros:
- Fully reporting SEC status
- Clinical trial & study infrastructure
- B2B expansion

Cons:
- Penny stock volatility
- Capital dilution
-Regulatory dependency (section 361)

Remember in Jan- Mar, they did all the certification of the rig and set up over MJ 02 and then evacuated the site due to hostilities.

They got back on site in May/June and then held the ASM. It was after that they got back on-site to prep MJ02 for drilling. Mid-June (at best) resta

Stock Market will be closed Friday, July 3rd, for the Celebration of 250 years of the Greatest Country ever!! 💥🎂🎉💥

Mentioned quite awhile back in my post……

“By the time the final list is locked down in June, institutional investors, arbitrageurs, and hedge funds have known about the potential inclusion since the initial preliminary list. “

https://investorshub.advfn.com/boards/read_